Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer. Cortes J, Punie K, Barrios C, Hurvitz SA, et al. N Engl J Med 2025 Oct 19. doi: 10.1056/NEJMoa2511734.

Read + Share

Amedeo Smart

Independent Medical Education

Cortes J, Punie K, Barrios C, Hurvitz SA, et al. Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer. N Engl J Med 2025 Oct 19. doi: 10.1056/NEJMoa2511734.
PMID: 41124233